Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice

Published:2017-02-20 Issue:6 Volume:38 Page:835-847
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zhang Tian,Prasad Preethy,Cai Ping,He Chunsheng,Shan Dan,Rauth Andrew Michael,Wu Xiao Yu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps2016166.pdf

Reference65 articles.

1. Pal SK, Childs BH, Pegram M . Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 2011; 125: 627–36.

2. Stockmans G, Deraedt K, Wildiers H, Moerman P, Paridaens R . Triple-negative breast cancer. Curr Opin Oncol 2008; 20: 614–20.

3. Irvin WJ Jr, Carey LA . What is triple-negative breast cancer? Eur J Cancer 2008; 44: 2799–805.

4. Telli ML, Carlson RW . First-line chemotherapy for metastatic breast cancer. Clin Breast Cancer 2009; 9: S66–72.

5. Griffiths CL, Olin JL . Triple negative breast cancer: a brief review of its characteristics and treatment options. J Pharm Pract 2012; 25: 319–23.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date);Discover Nano;2024-09-03

2. Advancing cancer therapy: Unveiling the cutting-edge potential of carmustine nano carriers for targeted treatment;Journal of Drug Delivery Science and Technology;2024-09

3. Biologically based strategies for overcoming in vivo barriers with functional nano‐delivery systems;Journal of Biochemical and Molecular Toxicology;2024-08

4. A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC);Journal of Nanoparticle Research;2024-05

5. In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer;Scientific Reports;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3